- Home
- SCWO vs GNFT Comparison
SCWO vs GNFT Comparison
Compare SCWO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- GNFT
- Stock Information
- Founded
- SCWO 2021
- GNFT 1999
- Country
- SCWO United States
- GNFT France
- Employees
- SCWO N/A
- GNFT N/A
- Industry
- SCWO Environmental Services
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCWO Utilities
- GNFT Health Care
- Exchange
- SCWO Nasdaq
- GNFT Nasdaq
- Market Cap
- SCWO 56.4M
- GNFT 214.5M
- IPO Year
- SCWO N/A
- GNFT 2019
- Fundamental
- Price
- SCWO $0.21
- GNFT N/A
- Analyst Decision
- SCWO
- GNFT Strong Buy
- Analyst Count
- SCWO 0
- GNFT 1
- Target Price
- SCWO N/A
- GNFT $13.00
- AVG Volume (30 Days)
- SCWO 1.3M
- GNFT 4.2K
- Earning Date
- SCWO 08-13-2025
- GNFT 04-24-2025
- Dividend Yield
- SCWO N/A
- GNFT N/A
- EPS Growth
- SCWO N/A
- GNFT N/A
- EPS
- SCWO N/A
- GNFT 0.03
- Revenue
- SCWO $673,267.00
- GNFT $73,187,701.00
- Revenue This Year
- SCWO $5,945.19
- GNFT $15.98
- Revenue Next Year
- SCWO $106.82
- GNFT N/A
- P/E Ratio
- SCWO N/A
- GNFT $125.30
- Revenue Growth
- SCWO 161.19
- GNFT 105.01
- 52 Week Low
- SCWO $0.16
- GNFT $2.55
- 52 Week High
- SCWO $1.99
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SCWO 34.76
- GNFT 47.81
- Support Level
- SCWO $0.16
- GNFT $3.61
- Resistance Level
- SCWO $0.44
- GNFT $3.95
- Average True Range (ATR)
- SCWO 0.06
- GNFT 0.14
- MACD
- SCWO -0.02
- GNFT -0.01
- Stochastic Oscillator
- SCWO 18.57
- GNFT 57.01
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.